What GLP-1s Really Cost in 2026 — and Every Way to Pay Less

List prices vs. real prices: insurance, manufacturer direct programs, savings cards, compounded options, and the questions to ask before paying anyone.

The honest price map Prices below are typical U.S. figures as of mid-2026; they move often, so treat them as a map rather than a quote. |, manufacturer direct (cash) | ≈$349–$549 | NovoCare (Wegovy) and LillyDirect (Zepbound vials) cut out the middlemen | | Brand, full list price | ≈$1,000–$1,400 | Almost nobody should pay this | | Compounded semaglutide (telehealth) | ≈$199–$399 | Cash-pay; includes provider visits at many programs | | Compounded tirzepatide (telehealth) | ≈$250–$450 | Cash-pay | | Generic liraglutide | varies, often <$300 | Daily injection, less weight loss — but the only generic GLP-1 | | Oral semaglutide (Rybelsus) | insurance-dependent | Diabetes indication; coverage easier with T2D diagnosis | ## Step 1: Exhaust insurance first - Check the formulary, not the rumor mill. Search your plan’s drug list for Wegovy, Zepbound, and Saxenda specifically — coverage for diabetes GLP-1s (Ozempic, Mounjaro) does not imply coverage for weight GLP-1s. - Prior authorization is normal. Typical requirements: BMI ≥ 30 (or ≥ 27 with a comorbidity), documented lifestyle attempts, sometimes a step through cheaper drugs. Your prescriber’s office files it; persistence pays — many denials are overturned on appeal. - Know the carve-outs. Many employer plans explicitly exclude weight-loss drugs; Medicare Part D historically excluded them (coverage exists for specific non-weight indications, like semaglutide for cardiovascular risk reduction after SELECT); Medicaid coverage varies by state. ## Step 2: Manufacturer programs (cash-pay, brand) If insurance says no, both manufacturers now sell directly to patients at a fraction of list: - NovoCare Pharmacy ships Wegovy to cash-pay patients (≈$499/month, sometimes lower for starter doses). - LillyDirect sells Zepbound single-dose vials (draw with a syringe instead of a pen) at ≈$349–$499/month depending on dose. - Savings cards knock commercial copays down (e.g., “as little as $25/month”) — but only if you have commercial insurance that covers the drug. ## Step 3: Compounded options (cash-pay, non-brand) Compounded semaglutide and tirzepatide from licensed 503A/503B pharmacies remain the cheapest GLP-1 route, typically $199–$450/month, often with clinician visits bundled. Understand what you are buying: a pharmacy-prepared, non-FDA-approved formulation prescribed when a clinician documents a need for a customized product — read compounded vs. brand before deciding, and vet any program against the checklist on where to get GLP-1s. Telehealth programs in this lane (alphabetically:, NexLife, and others) differ mainly on product breadth — injectable vs. sublingual forms, anti-nausea support, maintenance/microdose protocols — and on whether a human clinician is reachable after the sale. Price-compare on the total monthly cost including visits and shipping, not the teaser rate. ## Step 4: Squeeze the variables - Dose strategy is money. Staying at an effective middle dose instead of auto-escalating saves real dollars on vial-priced and compounded programs — and is legitimate clinical practice if you are losing well. - Maintenance costs less than loss. Once at goal, many patients hold results on lower or less-frequent dosing (microdosing guide), which cuts cost proportionally on per-mg-priced programs. - HSA/FSA funds apply to GLP-1 prescriptions and to telehealth visit fees. - Never “save money” on gray-market vials. Research-chemical semaglutide at $90/month is the most expensive thing on this page if it puts you in an ER. See how to spot scams.